p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy-Reference-Cited by-同舟云学术

p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy

Published:2004-07 Issue:1 Volume:210 Page:101-109
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Tang Reiping,Wang Jeng-Yi,Fan Chung-Wei,Tsao Kuo-Chien,Chen Hong-Hua,Wu Chi-Ming,Chen Jinn-Shiun,Changchien Chung Rong,Hsieh Ling-Ling

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference38 articles.

1. A genetic model for colorectal tumorigenesis;Fearon;Cell,1990

2. Genetic instability in colorectal cancers;Lengauer;Nature,1997

3. Genetic instabilities in human cancers;Lengauer;Nature,1998

4. Convention on nomenclature for DNA cytometry, Committee on Nomenclature, Society for Analytical Cytology;Hiddemann;Cancer Genet. Cytogenet.,1984

5. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial pre-disposition: development of international criteria for the determination of microsatellite instability in colorectal cancer;Boland;Cancer Res.,1998

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruthenium-Containing Linear Helicates and Mesocates with Tuneable p53-Selective Cytotoxicity in Colorectal Cancer Cells;Angewandte Chemie International Edition;2018-07-03

2. Ruthenium-Containing Linear Helicates and Mesocates with Tuneable p53-Selective Cytotoxicity in Colorectal Cancer Cells;Angewandte Chemie;2018-07-03

3. Major challenges related to tumor biological characteristics in accurate mutation detection of colorectal cancer by next-generation sequencing;Cancer Letters;2017-12

4. Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations;American Journal of Gastroenterology;2013-11

5. Association of TP53 Mutational Status and Gender with Survival after Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803;Clinical Cancer Research;2013-08-27